Use of anti-hepatitis C virus seropositive organs in liver transplantation

Transplant Proc. 1995 Feb;27(1):1204-5.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Analysis of Variance
  • Female
  • Follow-Up Studies
  • Hepacivirus / isolation & purification*
  • Hepatitis C / epidemiology*
  • Humans
  • Liver / pathology
  • Liver / virology*
  • Liver Transplantation / mortality
  • Liver Transplantation / pathology
  • Liver Transplantation / physiology*
  • Male
  • Postoperative Complications / epidemiology*
  • Probability
  • Recurrence
  • Risk Factors
  • Survival Rate
  • Time Factors